Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Miramar, Florida 33025


Purpose:

This study will assess platelet function and safety in healthy male volunteers following doses of intravenous diclofenac compared to oral diclofenac (Cataflam), intravenous ketorolac and oral aspirin.


Study summary:

The primary objective is to evaluate platelet function following intravenous diclofenac, oral diclofenac (Cataflam), intravenous ketorolac and oral aspirin.


Criteria:

Inclusion Criteria: - Healthy male subjects. - Willing and able to stay at the clinical site for approximately 8 nights over 9 days and to return to the clinic approximately 7 days after discharge. Exclusion Criteria: - Bleeding abnormalities or cardiovascular events. - Known allergy or hypersensitivity to the active compounds or any of the excipients used in the study.


NCT ID:

NCT00548678


Primary Contact:

Study Director
Javelin Pharmaceuticals
Javelin Pharmaceuticals


Backup Contact:

N/A


Location Contact:

Miramar, Florida 33025
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 17, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.